L

Lung Biotechnology PBC

14 employees

Lung Biotechnology PBC is engaged in the research and development, and marketing of therapies for pulmonary arterial hypertension (PAH)

Investor insights

Sectors invested in

Medical4

Health Care4

Cell Optimization2

Algae Biofuels2

Synthetic Biology2

Next Generation Genomics2

Cell Engineering2

Biodiscovery2

Scale-up2

Bioinformatics2

Fermentation2

Algae2

Gene Editing2

Renewable Energy2

Wellness2

Service Industry2

Medical Device2

Biotechnology2

Advanced Engineering2

Bioprocessing2

Funding rounds participated in

$50M sweet spot round size

Most of their 4 investments are in rounds between $12M and $50M

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology

Health Care

Medical

Pharmaceutical

Date founded

1997

Investments made

T

TransMedics, Inc. raised $13M on July 12, 2016

Investors: Abrams Capital, BioStar Ventures, Inbio Ventures, Kleiner Perkins, Flagship Ventures and Lung Biotechnology PBC

T

TransMedics, Inc. raised $51M on May 26, 2016

Investors: Abrams Capital, Millhouse, Inc. PLC, Kleiner Perkins, Flagship Ventures, Inbio Ventures, BioStar Ventures and Lung Biotechnology PBC

S

Synthetic Genomics raised $50M on September 22, 2015

Investors: Lung Biotechnology PBC

S

Synthetic Genomics raised $50M on April 1, 2014